LSPedia Newsletter

From Our CEO and Other Industry Experts

Find out how LSPedia is pushing forward the world of traceability. Our monthly newsletter is your guide to the serialized supply chain – from DSCSA compliance to industry events and technological advances – and beyond.

Icon graphic element

Current Issue - January/February 2026

Highlights

  • Compliance at Risk: Tightening DSCSA enforcement threatened Pioneer Pharmacy's wholesale operations and business continuity.
  • Enforcement Is Here: As of January 2026, FDA inspections now actively verify DSCSA compliance, with the first Form 483 issued to a dispenser following the end of the stabilization period.
  • Disconnected PMS, EHR, and inventory systems create redundant scanning, manual entry, and operational inefficiencies.
  • Pharmacies must obtain a GS1 Company Prefix from GS1 US to generate and manage compliant GLNs.
Network connection lines with dots showing data flow visualization

Explore Our Newsletter Archive

Nov/Dec 2025

In this edition: A regulator’s take on DSCSA, LSPedia achieves FedRAMP In-Process designation, pharmacists earn CE credits through hands-on DSCSA training, and more!

Sept/Oct 2025

In this edition: AI & ML are Revolutionizing Regulatory Affairs, Optimizing Supply Chains with ASNs, LSPedia CEO, Riya Cao Launches Executive Newsletter and more!

April/May 2025

DSCSA Enforcement Begins May 27 – 6 Critical Actions to Protect Your Shipments ‍FDA enforcement is around the corner. LSPedia outlines six key actions—like validating EPCIS connections and resolving exceptions—to help manufacturers and repackagers stay compliant and keep shipments moving.

February/March 2025

LSPedia’s Daniel MacKinnon met with leading pharma manufacturers in India frustrated by outdated systems and poor support. His latest blog explains why many are making the switch to LSPedia.

December/January 2024-2025

Discover how Baptist Health transformed compliance and operational workflows with LSPedia’s OneScan Suite.

October/November 2024

Matt Vincent, Director of Sales at LSPedia, breaks down the FDA’s DSCSA exemptions and their importance as the stabilization period ends on November 27, 2024.

August/September 2024

LSPedia is excited to introduce the new WEE Management Module as part of the upcoming OneScan 7.3 release on October 6, 2024.

June/July 2024

LSPedia has introduced a new Waivers, Exceptions, and Exemptions (WEEs) resource page, providing essential answers to pressing questions from those considering requesting a waiver for additional time to achieve DSCSA compliance and how to manage WEEs going forward with trading partners.

April/May 2024

In the pharmaceutical industry, maintaining a resilient and sustainable supply chain is paramount for ensuring product integrity, regulatory compliance, and operational efficiency.

February/March 2024

LSPedia launched OneScan 7.1, a leading traceability solution trusted by major healthcare brands globally.

December 2023/January 2024

Stay on track with DSCSA compliance new year. In this edition we talk about exciting news about LSPedia's selection to Veteran Affairs and much more

November, 2023

The DSCSA deadline is almost here. In this edition we are talking about our partnership with Redsail and much more

October, 2023

Welcome to our compliance update, click on the link to read more

Graphic elementGraphic element